See more : Kwung’s Holdings Limited (1925.HK) Income Statement Analysis – Financial Results
Complete financial analysis of EDAP TMS S.A. (EDAP) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of EDAP TMS S.A., a leading company in the Medical – Devices industry within the Healthcare sector.
- Borusan Mannesmann Boru Sanayi ve Ticaret A.S. (BRSAN.IS) Income Statement Analysis – Financial Results
- Silo Pharma, Inc. (SILO) Income Statement Analysis – Financial Results
- HealthStream, Inc. (HSTM) Income Statement Analysis – Financial Results
- Iowa First Bancshares Corp. (IOFB) Income Statement Analysis – Financial Results
- Siel Financial Services Limited (SIELFNS.BO) Income Statement Analysis – Financial Results
EDAP TMS S.A. (EDAP)
About EDAP TMS S.A.
EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST). The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment also offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; Ablatherm Fusion that incorporates the company's proprietary fusion software, which merges MRI and ultrasound images; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology; and offers Sonolith i-move, an extracorporeal shockwave lithotripter to small and mid-size hospitals, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. The company markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. Its customers include hospitals, urology clinics, and research institutions. The company was incorporated in 1979 and is headquartered in Lyon, France.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 60.42M | 55.11M | 44.07M | 41.66M | 44.91M | 39.18M | 35.75M | 35.61M | 32.25M | 26.79M | 24.08M | 26.07M | 22.29M | 23.71M | 24.89M | 23.05M | 22.36M | 20.27M | 20.79M | 22.15M | 18.44M | 19.98M | 24.01M | 27.33M | 19.16M | 23.19M | 32.73M |
| Cost of Revenue | 36.01M | 30.92M | 25.64M | 23.28M | 23.91M | 22.27M | 20.94M | 19.20M | 18.47M | 15.58M | 14.76M | 15.63M | 13.44M | 14.25M | 14.21M | 13.96M | 13.17M | 11.95M | 12.30M | 13.67M | 13.07M | 11.51M | 15.22M | 14.23M | 10.77M | 11.60M | 16.18M |
| Gross Profit | 24.41M | 24.19M | 18.42M | 18.38M | 21.00M | 16.92M | 14.81M | 16.41M | 13.79M | 11.20M | 9.32M | 10.43M | 8.86M | 9.46M | 10.67M | 9.10M | 9.19M | 8.32M | 8.49M | 8.48M | 5.37M | 8.47M | 8.79M | 13.10M | 8.39M | 11.60M | 16.55M |
| Gross Profit Ratio | 40.40% | 43.90% | 41.81% | 44.11% | 46.76% | 43.17% | 41.43% | 46.08% | 42.74% | 41.82% | 38.70% | 40.03% | 39.73% | 39.88% | 42.89% | 39.47% | 41.11% | 41.05% | 40.83% | 38.29% | 29.12% | 42.37% | 36.62% | 47.92% | 43.77% | 50.00% | 50.56% |
| Research & Development | 6.96M | 4.92M | 3.40M | 4.50M | 3.73M | 4.09M | 3.88M | 3.87M | 2.69M | 2.93M | 2.60M | 2.66M | 2.44M | 3.27M | 3.65M | 4.26M | 3.20M | 2.44M | 1.78M | 1.52M | 3.06M | 3.19M | 3.44M | 3.98M | 3.14M | 3.24M | 3.36M |
| General & Administrative | 14.63M | 7.15M | 5.90M | 4.34M | 4.22M | 3.59M | 3.43M | 3.30M | 3.20M | 3.33M | 3.20M | 3.19M | 3.04M | 3.32M | 3.82M | 3.86M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 22.63M | 16.38M | 10.73M | 9.28M | 10.85M | 10.55M | 9.53M | 8.86M | 7.41M | 6.68M | 6.28M | 6.62M | 5.87M | 6.68M | 6.40M | 5.68M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 37.26M | 23.53M | 16.63M | 13.61M | 15.07M | 14.14M | 12.95M | 12.15M | 10.61M | 10.01M | 9.48M | 9.81M | 8.92M | 10.01M | 10.22M | 9.55M | 9.87M | 8.70M | 8.03M | 7.47M | 10.44M | 9.92M | 9.59M | 11.51M | 11.57M | 12.96M | 12.55M |
| Other Expenses | 1.00K | 0.00 | 0.00 | -1.00K | 0.00 | 0.00 | 0.00 | 0.00 | 174.57K | 0.00 | 0.00 | -282.00K | 0.00 | 0.00 | 0.00 | 0.00 | 224.28K | 267.46K | 0.00 | 317.20K | -23.03K | 136.27K | 92.16K | 1.35M | 1.80M | 1.53M | 1.45M |
| Operating Expenses | 44.22M | 28.45M | 20.04M | 18.11M | 18.80M | 18.23M | 16.84M | 16.02M | 13.30M | 12.94M | 12.07M | 12.46M | 11.35M | 13.27M | 13.87M | 13.80M | 13.29M | 11.41M | 9.81M | 9.31M | 13.48M | 13.25M | 13.12M | 16.84M | 16.51M | 17.74M | 17.36M |
| Cost & Expenses | 80.24M | 59.37M | 45.68M | 41.39M | 42.71M | 40.50M | 37.77M | 35.22M | 31.77M | 28.52M | 26.84M | 28.10M | 24.79M | 27.53M | 28.09M | 27.76M | 26.46M | 23.36M | 22.12M | 22.98M | 26.55M | 24.76M | 28.33M | 31.07M | 27.28M | 29.33M | 33.55M |
| Interest Income | 1.31M | 404.00K | 10.00K | 10.00K | 20.00K | 19.00K | 18.00K | 21.00K | 18.00K | 31.00K | 59.00K | 126.00K | 185.00K | 265.00K | 252.00K | 412.00K | 331.28K | 224.28K | 186.59K | 146.06K | 177.07K | 455.52K | 992.41K | 0.00 | 0.00 | 511.60K | 0.00 |
| Interest Expense | 232.00K | 168.00K | 52.00K | 108.00K | 165.00K | 111.00K | 44.00K | 57.00K | 64.00K | 65.00K | 1.97M | 2.07M | 875.00K | 2.14M | 1.45M | 1.41M | 378.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 1.91M | 1.61M | 2.00M | 2.06M | 2.07M | 1.52M | 1.48M | 1.07M | 1.00M | 900.00K | 1.18M | 931.00K | 1.41M | 1.23M | 1.80M | 1.79M | 1.30M | 1.26M | 1.20M | 1.05M | 981.42K | 1.12M | 1.10M | 1.35M | 1.80M | 1.53M | 1.45M |
| EBITDA | -18.39M | -323.00K | 309.00K | 2.37M | 2.06M | 295.00K | 1.32M | 1.38M | 1.45M | 569.00K | -1.74M | -1.15M | -2.93M | -8.41M | -4.44M | 4.85M | -3.90M | -1.13M | -119.89K | 614.49K | -7.13M | -3.66M | -3.22M | -2.40M | -6.32M | -4.60M | 636.36K |
| EBITDA Ratio | -30.43% | -11.22% | -9.02% | 3.91% | 4.60% | -4.73% | -3.13% | 0.81% | -0.66% | -4.88% | -6.33% | -13.57% | -13.14% | -19.83% | -4.63% | -10.95% | -5.43% | -5.60% | -1.67% | 2.77% | -34.83% | -21.76% | -62.67% | -77.40% | -42.65% | -14.71% | -1.11% |
| Operating Income | -19.81M | -4.26M | -1.61M | -477.00K | 185.00K | -1.32M | -2.03M | 392.00K | 488.00K | -1.74M | -2.76M | -2.03M | -2.50M | 3.82M | 3.20M | 4.70M | 4.10M | 3.09M | 1.32M | 829.15K | 8.11M | 4.78M | 5.12M | 3.75M | -8.12M | 6.14M | -818.18K |
| Operating Income Ratio | -32.79% | -7.72% | -3.66% | -1.14% | 0.41% | -3.36% | -5.67% | 1.10% | 1.51% | -6.48% | -11.44% | -7.79% | -11.20% | 16.10% | 12.87% | 20.40% | 18.31% | 15.27% | 6.36% | 3.74% | 43.96% | 23.93% | 21.34% | 13.71% | -42.36% | 26.47% | -2.50% |
| Total Other Income/Expenses | -720.00K | 2.16M | 2.51M | -711.00K | 2.01M | 1.34M | 1.73M | 4.05M | -1.40M | 1.34M | -2.13M | -5.33M | 1.95M | -7.96M | -10.90M | -3.06M | -9.67M | -6.47M | -2.28M | -1.70M | -17.18M | -8.66M | 2.91M | 8.32M | 1.61M | -13.22M | 909.09K |
| Income Before Tax | -20.53M | -2.10M | 893.00K | -1.19M | 2.19M | 20.00K | -294.00K | 4.44M | -907.00K | -396.00K | -4.89M | -7.36M | -543.00K | -11.78M | -7.69M | 1.11M | -5.58M | -3.37M | -959.98K | -870.46K | -9.07M | -3.88M | 8.03M | 12.07M | -6.51M | -7.08M | 90.91K |
| Income Before Tax Ratio | -33.98% | -3.80% | 2.03% | -2.85% | 4.88% | 0.05% | -0.82% | 12.48% | -2.81% | -1.48% | -20.29% | -28.23% | -2.44% | -49.68% | -30.92% | 4.79% | -24.95% | -16.65% | -4.62% | -3.93% | -49.21% | -19.40% | 33.46% | 44.15% | -33.95% | -30.51% | 0.28% |
| Income Tax Expense | 644.00K | 837.00K | 193.00K | 516.00K | 679.00K | 358.00K | 388.00K | 602.00K | 759.00K | 116.00K | 135.00K | 118.00K | 395.00K | 939.00K | 72.00K | -492.00K | -139.92K | 56.07K | 103.85K | 278.11K | -113.55K | 166.77K | 883.39K | 323.68K | -256.40K | 85.27K | -90.91K |
| Net Income | -21.18M | -2.93M | 700.00K | -1.70M | 1.51M | -338.00K | -681.00K | 3.84M | -1.67M | -512.00K | -5.02M | -7.48M | -938.00K | -12.72M | -7.77M | 1.60M | -5.44M | -3.43M | -1.06M | -1.15M | -8.96M | -4.04M | 7.15M | 11.74M | -6.25M | -7.16M | 181.82K |
| Net Income Ratio | -35.05% | -5.32% | 1.59% | -4.09% | 3.37% | -0.86% | -1.91% | 10.79% | -5.17% | -1.91% | -20.85% | -28.68% | -4.21% | -53.64% | -31.21% | 6.93% | -24.32% | -16.93% | -5.12% | -5.18% | -48.59% | -20.24% | 29.78% | 42.97% | -32.61% | -30.88% | 0.56% |
| EPS | -0.57 | -0.09 | 0.02 | -0.06 | 0.05 | -0.01 | -0.02 | 0.14 | -0.07 | -0.02 | -0.24 | -0.43 | -0.07 | -0.98 | -0.74 | 0.17 | -0.59 | -0.39 | -0.14 | -0.15 | -1.15 | -0.52 | 0.92 | 1.50 | -0.80 | -0.86 | 0.03 |
| EPS Diluted | -0.57 | -0.09 | 0.02 | -0.06 | 0.05 | -0.01 | -0.02 | 0.13 | -0.07 | -0.02 | -0.24 | -0.43 | -0.07 | -0.97 | -0.73 | 0.17 | -0.59 | -0.36 | -0.13 | -0.14 | -1.15 | -0.52 | 0.90 | 1.42 | -0.80 | -0.86 | 0.03 |
| Weighted Avg Shares Out | 37.00M | 34.39M | 32.13M | 29.15M | 29.02M | 29.00M | 28.96M | 27.82M | 23.81M | 23.60M | 20.59M | 17.38M | 13.35M | 13.01M | 10.51M | 9.58M | 9.20M | 8.82M | 7.78M | 7.78M | 7.78M | 7.77M | 7.76M | 7.78M | 7.80M | 8.32M | 6.67M |
| Weighted Avg Shares Out (Dil) | 37.00M | 34.39M | 32.42M | 29.15M | 29.62M | 29.00M | 28.96M | 29.37M | 25.02M | 23.60M | 20.59M | 17.56M | 13.35M | 13.09M | 10.57M | 9.66M | 9.20M | 9.56M | 8.37M | 8.07M | 7.82M | 7.83M | 7.94M | 8.27M | 7.80M | 8.32M | 6.67M |
EDAP Announces Record Preliminary Fourth Quarter and Full-Year 2023 Revenues
EDAP Announces Preliminary Fourth Quarter Record Focal One® System Sales and Placements
EDAP Appoints Ken Mobeck, Global Chief Financial Officer, and Francois Dietsch, Global Chief Accounting Officer
EDAP Announces Positive Opinion for Reimbursement from the French National Authority for Health (HAS) for HIFU treatment of Prostate Cancer
EDAP Appoints Lance Willsey, M.S., M.D. to Board of Directors
EDAP Receives 2023 Industry Category Award from the French National Institute for Intellectual Property (INPI) for Its Therapeutic Ultrasound Technology
EDAP to Present at Piper Sandler's 35th Annual Healthcare Conference
EDAP TMS S.A. (EDAP) Q3 2023 Earnings Call Transcript
EDAP Announces Third Quarter 2023 Financial Results
EDAP to Present at the Jefferies London Healthcare Conference
Source: https://incomestatements.info
Category: Stock Reports